Volume 32, Number 1—January 2026
Research
Enhanced Isolation and Detection of COVID-19 in Hospitalized Patients Undergoing Antiviral Therapy
Figure 2

Figure 2. Viral culture isolation rates from nasal swabs of nonimmunocompromised patients infected with SARS-CoV-2 variants of concern from study on the enhanced isolation and detection of COVID-19 in hospitalized patients undergoing antiviral therapy. Nasal swabs (n = 148) PCR-confirmed positive for wild-type, Delta, BA.1, BA.2, BQ, BA.5, and XBB.1 SARS-CoV-2 variants of concern were cultured in triplicate on 3 different cell lines. Error bars indicate SDs. Vero E6 T2, Vero E6 cells expressing transmembrane protease serine 2; Vero E6 A2T2, Vero E6 cells expressing both transmembrane protease serine 2 and angiotensin-converting enzyme 2.
Page created: December 30, 2025
Page updated: January 29, 2026
Page reviewed: January 29, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.